Synthesis, Biological Evaluation, and Computational Insights of Organyltellurium(IV) Complexes With 5‐Substituted Furan Ligand
Applied Organometallic Chemistry,
Journal Year:
2025,
Volume and Issue:
39(4)
Published: March 20, 2025
ABSTRACT
Organyltellurium(IV)
complexes
have
attracted
significant
attention
due
to
their
structural
versatility
and
promising
biological
applications.
In
this
study,
a
series
of
novel
organyltellurium(IV)
with
5‐substituted
furan‐based
ligands
were
designed,
synthesized,
evaluated
for
antioxidant,
antimicrobial,
anti‐inflammatory
properties.
The
synthesized
compounds
characterized
by
ultraviolet–visible
(UV–Vis),
FT‐IR,
1
H‐NMR,
13
C‐NMR,
mass
spectrometry,
molar
conductance,
elemental
analysis,
powder
X‐ray
diffraction
thermal
analyses
which
states
that
the
bidentate
Schiff
base
ligand
(MeF4AP)
coordinated
via
oxygen
nitrogen
atom
tellurium
giving
hexa‐coordinated
tellurium(IV)
complexes.
silico
studies,
including
molecular
docking,
density
functional
theory
(DFT)
calculations,
MESP
ADME
profiling
provided
insights
into
stability,
electronic
properties,
pharmacokinetic
potential.
DPPH
BSA
assays
revealed
3c
(IC₅₀
=
4.95
±
0.02
μM),
3b
7.12
0.07
μM
3f
4.14
0.11
μM)
exhibited
highest
antioxidant
activity
compared
ligand.
Notably,
complex
MIC
0.20
mg/mL
against
Candida
albicans
nearly
twice
as
potent
standard
drug
griseofulvin
(MIC
0.50
mg/mL).
FMO
studies
supports
more
bioactivity
base.
displayed
most
reactive
regions.
strong
correlation
between
computational
predictions
in
vitro
results
highlights
potential
these
multifunctional
therapeutic
candidates
pave
way
further
exploration
biomedical
Language: Английский
Exploring Anticancer Activity and DNA Binding of Metal (II) Salicylaldehyde Schiff Base Complexes: A Convergence of Experimental and Computational Perspectives
Applied Organometallic Chemistry,
Journal Year:
2025,
Volume and Issue:
39(5)
Published: April 9, 2025
ABSTRACT
Metal
complexes
derived
from
salicylaldehyde‐based
Schiff
bases
are
among
the
frontrunners
in
pursuit
of
precise
and
potent
cancer
treatments
due
to
their
remarkable
prowess.
In
this
study,
base
(
HL
)
was
prepared
via
a
reaction
between
2‐amino‐5‐benzonitrile
salicylaldehyde.
Subsequently,
further
reacted
with
Ni
(II),
Co
Cu
(II)
Pd
ions
using
respective
metal
salts
obtain
homoleptic
mononuclear
C1
–
C4
).
The
composition
were
determined
1
H
13
C
NMR,
UV–Vis,
FTIR,
CHN,
SEM–EDX
HRMS
analyses.
addition,
structural
geometries
,
C3
solid
state
single
crystal
X‐ray
diffraction
analysis
corroborate
mentioned
characterization
techniques
employed.
stability
compounds
assessed
through
time‐dependent
UV–vis
spectroscopy,
revealing
that
C2
exhibited
highest
under
experimental
conditions.
anticancer
effects
tested
on
breast
cell
lines
(MCF‐7)
MTT,
LDH
ATP
assays.
Both
displayed
potential
cytotoxicity
MCF‐7
line,
which
better
inhibition
effect
than
standard
chemotherapeutic
agent,
doxorubicin
(DOX),
IC
50
43.08
μM.
We
postulate
mechanism
by
may
function
is
binding
DNA
=
0.114
(±
0.02)
×
10
4
intercalation
(shown
UV‐CD
UV‐LD
spectroscopy)
at
AT
rich
sites.
These
data
corroborated
silico
extra
precision
(XP)
docking
molecular
dynamic
(MD)
simulations.
Language: Английский
Sulfaquinoxaline-Derived Schiff Bases: Synthesis, Characterization, Biological Profiling, and Computational Modeling
Journal of Molecular Structure,
Journal Year:
2024,
Volume and Issue:
unknown, P. 140231 - 140231
Published: Sept. 1, 2024
Language: Английский
Synthesis, Characterization, Biological Evaluation, Dft, and Molecular Docking Study of a Co(Ii) Complex Derived from on Donor Bidentate Schiff Base Ligand
Ibrahim Waziri,
No information about this author
Musa B. Ismaila,
No information about this author
Grema A. Mala
No information about this author
et al.
Published: Jan. 1, 2024
Language: Английский
Synthesis, Characterization, Biological Evaluation, DFT, and Molecular Docking Study of a Co(II) Complex Derived from ON Donor Bidentate Schiff Base Ligand
Musa B. Ismaila,
No information about this author
Grema A. Mala,
No information about this author
Usman Umaru
No information about this author
et al.
ChemistrySelect,
Journal Year:
2024,
Volume and Issue:
9(40)
Published: Oct. 1, 2024
Abstract
The
utilization
of
biologically
active
metal
complexes
in
medicine
is
gaining
recognition
as
an
alternative
approach
to
traditional
organic
molecules,
which
often
exhibit
undesirable
side
effects.
This
study
focuses
on
the
synthesis
and
characterization
a
Co(II)
complex
derived
from
(
E
)‐2‐((2‐hydroxybenzylidene)amino)‐5‐methylbenzonitrile
ligand
system
(HL)
cobalt(II)
acetate
tetrahydrate
dichloromethane/methanol
solution.
A
comprehensive
strategy
was
employed,
involving
proton
carbon
nuclear
magnetic
resonance,
infrared,
electronic
spectra,
PXRD,
SEM‐EDX,
mass
spectroscopies,
well
elemental
analysis
(CHN
Co),
TGA,
molar
conductance,
confirm
chemical
structures
its
complex.
infrared
spectral
data
revealed
bidentate
ligand,
chelating
ion
through
oxygen
nitrogen
atoms
phenolate
imine
groups.
Additionally,
PXRD
SEM
analyses
indicated
crystalline
amorphous
properties
for
complex,
respectively.
Assessment
antimicrobial
potential
using
modified
disc
diffusion
method,
with
streptomycin
positive
control,
demonstrated
complex's
enhanced
antibacterial
activity
compared
against
all
tested
bacteria,
showing
concentration‐dependent
response.
Similarly,
antioxidant
studies
promising
results,
exhibiting
superior
DPPH
radical
scavenging
(IC
50
values:
64.5
μg.mL
−1
,
43.1
).
Theoretical
DFT
calculations
molecular
docking
provided
insights
into
binding
affinity
supporting
experimental
findings
affirming
biological
activities
exhibited
by
compounds.
Overall,
this
research
showcases
synthesis,
characterization,
evaluation
highlighting
effective
agent.
Language: Английский